Literature DB >> 15342185

The effect of penetration enhancers on drug delivery through skin: a QSAR study.

Taravat Ghafourian1, Parinaz Zandasrar, Hamed Hamishekar, Ali Nokhodchi.   

Abstract

Skin penetration enhancers are used to allow formulation of transdermal delivery systems for drugs that are otherwise insufficiently skin-permeable. A full understanding of the mode of action could be beneficial for the design of potent enhancers and for the choice of the enhancer to be used in the topical formulation of a special drug. In this study, the structural requirements of penetration enhancers have been investigated using the Quantitative Structure-Activity Relationship (QSAR) technique. Activities of naturally occurring terpenes, pyrrolidinone and N-acetylprolinate derivatives on the skin penetration of 5-fluorouracil, diclofenac sodium (DFS), hydrocortisone (HC), estradiol and benazepril have been considered. The resulting QSARs indicated that for 5-fluorouracil and diclofenac sodium, less hydrophobic enhancers were the most active. More precisely, molecular descriptors in the corresponding QSARs indicated the possible involvement of intermolecular electron donor-acceptor interactions. This was in contrast to the skin permeation promotion of hydrocortisone, estradiol and benazepril by enhancers, where a linear relationship between enhancement activity and n-octanol/water partition coefficients of enhancers was evident. The possible mechanisms of penetration enhancement as suggested by the QSARs will be discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342185     DOI: 10.1016/j.jconrel.2004.06.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  Design principles of chemical penetration enhancers for transdermal drug delivery.

Authors:  Pankaj Karande; Amit Jain; Kaitlin Ergun; Vincent Kispersky; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

2.  The effect of Neuragen PN on neuropathic pain: A randomized, double blind, placebo controlled clinical trial.

Authors:  Li Li
Journal:  BMC Complement Altern Med       Date:  2010-05-20       Impact factor: 3.659

3.  A skin permeability model of insulin in the presence of chemical penetration enhancer.

Authors:  K M Yerramsetty; B J Neely; S V Madihally; K A M Gasem
Journal:  Int J Pharm       Date:  2009-12-21       Impact factor: 5.875

4.  Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement (E(max)).

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

Review 5.  Percutaneous permeation enhancement by terpenes: mechanistic view.

Authors:  Bharti Sapra; Subheet Jain; A K Tiwary
Journal:  AAPS J       Date:  2008-02-08       Impact factor: 4.009

6.  Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax.

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Control Release       Date:  2009-02-06       Impact factor: 9.776

7.  A Molecular Interpretation on the Different Penetration Enhancement Effect of Borneol and Menthol towards 5-Fluorouracil.

Authors:  Ran Wang; Zhimin Wu; Shufang Yang; Shujuan Guo; Xingxing Dai; Yanjiang Qiao; Xinyuan Shi
Journal:  Int J Mol Sci       Date:  2017-12-18       Impact factor: 5.923

8.  Molecular determinants of juvenile hormone action as revealed by 3D QSAR analysis in Drosophila.

Authors:  Denisa Liszeková; Maja Polakovicová; Milan Beno; Robert Farkas
Journal:  PLoS One       Date:  2009-06-23       Impact factor: 3.240

9.  Design of skin penetration enhancers using replacement methods for the selection of the molecular descriptors.

Authors:  Laurent Simon; Beshoy Abdelmalek
Journal:  Pharmaceutics       Date:  2012-07-11       Impact factor: 6.321

10.  Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery.

Authors:  Srujan Marepally; Cedar H A Boakye; Punit P Shah; Jagan Reddy Etukala; Adithi Vemuri; Mandip Singh
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.